Turnaround story: 40 smallcaps that lost over 30% in FY23, turn multibaggers in FY24

The FY24 has been a turnaround year for smallcap stocks, witnessing a significant rally with many stocks turning multibaggers. However, concerns over valuations raised by Sebi might moderate returns in FY25. While equity bulls partied hard in most of FY24, the Securities and Exchange Board India (Sebi) turned a party spoiler towards the end.

MUMBAI: Undoubtedly, the current financial year has been a remarkable one for the little ninjas of – – as we saw as many as 181 of them turning .

What’s worth noting is that more than 100 of these smallcap stocks went through a bad phase in the preceding financial year. So, became a year for many of them.

Among these, ETMarkets filtered out stocks that corrected more than 30% in FY23 but turned multibaggers in FY24, and found 40 such smallcaps.

Favourable risk-reward, coupled with strong earnings growth and robust domestic macroeconomic environment played in favour of the smallcaps and this triggered the stellar rally in the smallcap universe.

So far in FY24, the S&P BSE Smallcap index has rallied a whopping 59%, after correcting over 4% in FY23. In comparison, benchmark Sensex has gained 23.5% in FY24, compared to just 0.7% gain in FY23.
You Might Also Like:

Pharmaceutical company Kopran Ltd was the biggest loser in FY23, shedding 61%, but the stock rebounded sharply in FY24 and gave 135% returns to investors.

Alok Industries, owned by , is another turnaround story in the smallcap universe. The stock, which fell more than 54% in FY23, rallied 147% in the current financial year. This rally was partly on the back of the fund infusion by the parent. infused Rs 3,300 crore capital in Alok Industries in January.

Several smallcap real estate companies are part of FY24 multibaggers list, as higher investments by the government on infrastructure and strong demand for premium residential spaces bolstered the outlook for the sector.

Shares of , , and are the smallcap stocks that gave multibagger returns of 126-195% in FY24. In FY23, these stocks corrected 32-53% in FY23.
You Might Also Like:

Besides Kopran, there were many stocks in the pharmaceutical stocks which rebounded sharply this year after the underperformance last year.

, , and stocks corrected 37-43% in FY23, but they more than doubled in value in the current financial year, giving returns of 105-210%.

Will History repeat in FY25?

While partied hard in most of FY24, the Securities and Exchange Board India turned a party spoiler towards the end. The regulator raised concerns over the skyrocketing valuations and also directed mutual funds to take measures to check the unprecedented inflows into midcap and smallcap funds.
You Might Also Like:

This has dampened the euphoria to an extent, and market experts believe that the returns in smallcap stocks will moderate in FY25.

“Given the sharp rally in the broader markets and frothy valuations in a few pockets, our current stance is conservative,” said Poonam Tandon, chief investment officer at IndiaFirst Life.

“Our broad approach continues to remain stock-specific with a preference for quality companies with the ability to maintain margins backed by a healthy balance sheet that can navigate this turbulent macro environment,” she said.

Kshitiz Mahajan of Complete Circle Wealth recommends investors, who are looking to allocate funds in small and midcap, to align their long-term goals with these categories of funds.

“It's crucial to diversify across various asset classes and not allocate based solely on past returns. Industry flows in small and midcap stocks may also come through other categories,” he said.

(Data inputs from Ritesh Presswala)

(Disclaimer: Recommendations, suggestions, views and opinions given by the experts are their own. These do not represent the views of The Economic Times)

Source: Stocks-Markets-Economic Times

Последние публикации
Analysis-New alumina supplies in 2025 poised to rupture record price rally
15.11.2024 - 06:00
Netflix hopes for live sports knockout with Paul-Tyson fight
15.11.2024 - 05:00
Lenovo plans global factory expansion as Q2 results beat; eyes AI growth
15.11.2024 - 05:00
Hyundai Motor picks first foreign CEO in reshuffle as it braces for Trump
15.11.2024 - 05:00
Asia stocks skittish as rate cut bets wane; China, Japan data offer mixed cues
15.11.2024 - 04:00
Starting Latin America trip, Xi Jinping opens huge port in Peru funded by China
15.11.2024 - 04:00
Canada's labour board orders operations to resume at Montreal port
15.11.2024 - 04:00
Nissan shares surge after report activist investor Oasis has stake
15.11.2024 - 03:00
Hyundai Motor names U.S. chief Jose Munoz as CEO in major reshuffle
15.11.2024 - 03:00
Factbox-RFK Jr.'s plan for changing the U.S. food and drug system
15.11.2024 - 03:00
GM self-driving unit Cruise admits to submitting false report, will pay $500,000 fine
15.11.2024 - 03:00
Citigroup facing US probe over ties to sanctioned Russian billionaire, Barron's reports
15.11.2024 - 03:00
US man sentenced to 5 years over laundering crypto stolen from Bitfinex hack
15.11.2024 - 02:00
Lenovo Q2 profit jumps 44% on AI demand boost
15.11.2024 - 02:00
Glenview, Sachem Head, Third Point buy CVS shares during Q3-filings
15.11.2024 - 02:00

© Analytic DC. All Rights Reserved.

new
Анализ рынка Как повлият завтра отчет NFP на курс доллара США?